Search
Showing results for "1"
Research
A novel role for interleukin-1 receptor signaling in the developmental regulation of immune responses to endotoxinSuggests that IL-1R1 expression provides an additional level of Myd88-dependent signaling during this period of heighted susceptibility to infection.
Research
Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral LeishmaniasisHere we employ whole blood assays to evaluate human cytokine responses to 11 of these antigens, in comparison to known defined and crude antigen preparations.
Research
Maternal work hours in early to middle childhood link to later adolescent diet qualityPrevious studies on maternal work hours and child diet quality have reported conflicting findings possibly due to differences in study design, lack of a...
Research
The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localizedMucosal leishmaniasis (ML) follows localized cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au Respiratory Syncytial
News & Events
Launching DiabHQ app this World Diabetes DayInnovative new digital platform set to transform diabetes care for WA families.
News & Events
New research on youth-onset type 2 diabetes in northern AustraliaExplore new research on youth-onset diabetes at The Kids' Institute, uncovering insights to improve health outcomes for young patients in Northern Australia.
Information from the Healthy Pregnancy & Me brochure for health professionals on how to raise the topic of gestational weight gain.
Research
Maximising fathers’ roles in preventing adolescent alcohol-related harm. (Fathers and Adolescent Alcohol Use Project)This project will explore fathers’ attitudes and behaviours regarding the alcohol-related parenting of 10-17-year-old children.
In 2014, Wesfarmers committed $5 million over 4 years to The Kids' research to set up the Wesfarmers Centre of Vaccines and Infectious Diseases.